Positive Outlooks

Stories to make you feel better.

☰
  • Home
    • About Us
  • Stories
    • Health | Wellness
    • Quotes
  • Reflections
  • Submissions
  • Contact Us
  • Home
  • medicines

Nasal spray could help those who have no success with available depression treatments

Recently, the U.S. FDA approved esketamine, a fast-acting drug derived from the anesthetic, ketamine, that is intended to aid the treatment-resistant population of people with depression. There are about 16.2 million Americans who suffer from major depression, and as many as a quarter of them reported achieving little to no results from available treatments, including FDA

Read more →

Tagged with 
depression esketamine health Janssen Pharmaceuticals Johnson & Johnson ketamine medical treatment medicines pharmaceutical innovation science Spravato
 
Follow us on Pinterest!
Categories
Archives
Follow Us
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
Our TOP Stories
Hundreds of Amish men move barn using only their hands in an impressive show of teamwork
Mom of biracial twins hopes her daughters will encourage people to 'love everyone equal'
This sand artist creates animal sculptures so incredibly detailed, they almost look real
This glass-domed train will take you on a delightful trip across the scenic Southwest in luxury

Privacy Policy of Positive Outlooks
×Close